In the News December 31, 2014
Total Page:16
File Type:pdf, Size:1020Kb
From: [email protected] on behalf of Lindo, Allisa Subject: Mount Sinai In The News - December 31, 2014 Date: Wednesday, December 31, 2014 11:36:49 AM Attachments: ATT00001.txt In the News December 31, 2014 Psych Central - December 28 Rat Study Finds ALS Drug May Prevent Age-Related Memory Loss – Janice Wood A new study on rats suggests an existing drug, riluzole, may help prevent “foggy brain,” characterized by fading memory and clouding judgment as we age. The forgetfulness is caused by lost and altered connections between neurons in the brain. But researchers at Rockefeller University and The Icahn School of Medicine at Mount Sinai in New York found they could stop normal, age-related memory loss in rats by treating them with riluzole, a drug currently used to treat the neurodegenerative condition ALS, also known as Lou Gehrig’s Disease. - Dr. John Morrison, Professor, Neuroscience, Geriatrics and Palliative Care, Dean of Basic Sciences and the Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai Learn more: http://psychcentral.com/news/2014/12/28/rat-study-finds-existing-drug-may-prevent- memory-loss-as-we-age/79162.html Additional Coverage: New Hampshire Voice: http://nhv.us/content/14121243-als-drug-could-treat-age-related-cognitive- decline Science 2.0: http://www.science20.com/news_articles/als_drug_reduces_the_memory_fog_of_old_age- 151755 The Times of India - December 31 Feeling Drained Out? It's More Serious Than You Think How often do you feel irritated, tired and completely defeated? You might be suffering from vital exhaustion! Vital exhaustion is defined as excessive fatigue, feelings of demoralization and increased irritability. Recent research shows that this condition may increase your risk for a heart-related event even if you are otherwise healthy. Researchers at the Mount Sinai St. Luke's-Roosevelt Hospital Center, New York studied the connection between vital exhaustion and first-time heart disease in 11 prospective studies that involved more than 60,000 people without heart disease. - Mount Sinai St. Luke’s and Mount Sinai Roosevelt Hospitals Learn more: http://timesofindia.indiatimes.com/life-style/health-fitness/health/Feeling-drained-out-Its- more-serious-than-you-think/articleshow/45701614.cms Becker’s ASC Review - December 30 New York Board of Medicine appoints Dr. Lawrence Epstein – Anuja Vaidya Lawrence Epstein, MD, has been appointed to the New York Board of Medicine, according to an ASA report. Dr. Epstein is the immediate past president of the New York State Society of Anesthesiologists. He is currently the director of outpatient pain management in the department of anesthesiology at Mount Sinai Hospital in New York. Dr. Epstein's term with the New York Board of Medicine began in December and will conclude in 2019. - Dr. Lawrence Epstein, Associate Professor, Anesthesiology, Neurology, Icahn School of Medicine at Mount Sinai Learn more: http://www.beckersasc.com/anesthesia/new-york-board-of-medicine-appoints-dr- lawrence-epstein.html Everyday Health - December 22 Relief in Sight for the Unrelenting Itch of Eczema – Dr. Sanjay Gupta The itch of severe eczema is so debilitating, it almost cost Neal Patel his future. He was in medical school, and his eczema prevented him from sleeping and studying. Today Patel is almost disease free — and he’s a doctor. He credits Emma Guttman, MD, PhD, a researcher at the Icahn School of Medicine at Mount Sinai. “Finding Dr. Guttman… has really saved my life,” he says. - Dr. Emma Guttman, Associate Professor, Medicine, Dermatology, Clinical Immunology, Icahn School of Medicine at Mount Sinai Learn more: http://www.everydayhealth.com/news/relief-in-sight-for-unrelenting-itch-eczema/? xid=aol_eh-skin_3_20141222_&aolcat=HLT Stylelist - December 30 Break Out The Same Time Every Month? How to Stop Hormonal Acne Hormonal acne isn't like all other types of acne. It's often along the jawline, chin and neck and is usually cystic with big, red, painful bumps. It's exactly these types of bumps that can't be hidden, no matter how good your concealer is. Dr. Joshua Zeichner, a New York dermatologist and Director of Cosmetic & Clinical Research at Mt. Sinai Medical Center, explains, "As hormones rise, they can stimulate oil production from the skin's sebaceous glands. This translates into clogged pores and pimples." - Dr. Joshua Zeichner, Assistant Professor, Dermatology, Icahn School of Medicine at Mount Sinai Learn more: http://www.stylelist.com/read/break-out-the-same-time-every-month-how-to-stop- hormonal-acne/?icid=stylelist|beauty|makeup|link1|topnav Youth Health Magazine - December 30 New Study Linked To Hearing Loss in Older Adults A new study from the San Diego State University has revealed that older adults living with Human Immunodeficiency Virus (HIV) has more tendency to have hearing loss than those people who does not have the AIDS (Acquired Immunodeficiency Syndrome)-causing virus. One expert, Dr. Eric Smouha, director of otology-neurology at the Icahn School of Medicine at Mount Sinai, New York City said that the study suggests that HIV may have an effect on the inner ear of the person. -Dr. Eric Smouha, Associate Professor, Otolaryngology, Icahn School of Medicine at Mount Sinai Learn more: http://www.youthhealthmag.com/articles/6134/20141230/new-study-linked-to-hearing-loss- in-older-adults.htm If you have a news story, news tip, breakthrough, study, upcoming event or patient success story to share or have been contacted by the media for an interview contact: [email protected] 212-241-9200 From: [email protected] on behalf of Lindo, Allisa Subject: Mount Sinai In The News - December 30, 2014 Date: Tuesday, December 30, 2014 11:14:42 AM Attachments: ATT00001.txt In the News December 30, 2014 The American Scholar - December 17 Tougher Than We Think – Josie Glausiusz Although rates vary, one study shows that only about eight percent of people will develop post- traumatic stress disorder (PTSD) in the wake of such a severe trauma. According to Steven Southwick of Yale University School of Medicine and Dennis Charney of the Icahn School of Medicine at Mount Sinai, the authors of 2012 review of resilience in the journal Science, repeated incidents of uncontrollable stress during infancy and childhood can affect brain development, leading to learned helplessness that can continue into adulthood. Now, a team of researchers led by neuroscientists Caroline Dias, Jian Feng, and Eric Nestler of Icahn School of Medicine at Mount Sinai in New York City has identified a single protein in the brain that promotes resilience to chronic stress. - Dr. Dennis Charney, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and President for Academic Affairs for the Mount Sinai Health System, Professor Psychiatry, Neuroscience Pharmacology and Systems Therapeutics at Icahn School of Medicine at Mount Sinai - Dr. Eric J. Nestler, Nash Family Professor, Chair of the Department of Neuroscience and Director of the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai - Jian Feng, Postdoctoral Fellow, Neuroscience, Icahn School of Medicine at Mount Sinai -Caroline Dias, Medical Student, Icahn School of Medicine at Mount Sinai Learn more: https://theamericanscholar.org/tougher-than-we-think/#.VKGiPcBB Oncology Times – January 2015 HCC: Negative Results for Sorafenib in Adjuvant Setting and Combined with Chemotherapy – Sarah DiGuilio The latest data from the STORM trial, presented during the plenary session at the ILCA meeting as well as at the 2014 American Society of Clinical Oncology Annual Meeting, showed that sorafenib does not improve recurrence-free survival for patients with hepatocellular carcinoma in the adjuvant setting (ASCO Abstract 4006).“Sorafenib is the sole drug approved for management of advanced HCC cases,” study author Josep M. Llovet, MD, said in an email. Llovet is a Professor of Medicine and Director of the Liver Cancer Program at Icahn School of Medicine at Mount Sinai. - Dr. Josep Llovet, Professor, Medicine, Liver Diseases, Director, HCC Program, Icahn School of Medicine at Mount Sinai Learn more: http://journals.lww.com/oncology- times/Fulltext/2015/01100/HCC__Negative_Results_for_Sorafenib_in_Adjuvant.9.aspx HC Pro – December 30 Experts answer questions about how to better provide social support to patients Healthcare experts today are increasingly focused on things besides medicine that help to keep people well, including social factors such as access to food and shelter, money to pay for treatments, and education. On September 30, the Commonwealth Fund tackled this topic in a webinar called “The Business Case for Addressing Patients’ Social Needs in Health Care Delivery.” The webinar was presented by Deborah Bachrach, partner at Manatt, Phelps & Phillips in Albany, New York; Jennifer DeCubellis, assistant county administrator–health, Hennepin County, Minnesota; and Jeremy Boal, M.D., executive vice president for clinical operations and chief medical officer at Mount Sinai Health System in New York. - Dr. Jeremy Boal, Executive Vice President, Chief Medical Officer, Mount Sinai Health System Learn more: http://www.hcpro.com/CAS-311565-12341/Experts-answer-questions-about-how-to-better- provide-social-support-to-patients.html Healthday – December 24 Breast Cancer Chemo Tied to Small but Significant Leukemia Risk – Alan Mozes Among early stage breast cancer patients who undergo chemotherapy and/or radiation treatment, less than half of one percent will eventually develop